vs

Side-by-side financial comparison of Garmin (GRMN) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

Garmin is the larger business by last-quarter revenue ($2.1B vs $1.5B, roughly 1.4× BeOne Medicines Ltd.). Garmin runs the higher net margin — 24.9% vs 4.4%, a 20.4% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 16.6%). Garmin produced more free cash flow last quarter ($429.6M vs $379.8M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 24.0%).

Garmin Ltd. is an American multinational technology company based in Olathe, Kansas. The company designs, develops, manufactures, markets, and distributes GPS-enabled products and other navigation, communication, sensor-based, and information products to the automotive, aviation, marine, outdoors, and sport markets.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

GRMN vs ONC — Head-to-Head

Bigger by revenue
GRMN
GRMN
1.4× larger
GRMN
$2.1B
$1.5B
ONC
Growing faster (revenue YoY)
ONC
ONC
+16.2% gap
ONC
32.8%
16.6%
GRMN
Higher net margin
GRMN
GRMN
20.4% more per $
GRMN
24.9%
4.4%
ONC
More free cash flow
GRMN
GRMN
$49.8M more FCF
GRMN
$429.6M
$379.8M
ONC
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
24.0%
GRMN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRMN
GRMN
ONC
ONC
Revenue
$2.1B
$1.5B
Net Profit
$528.7M
$66.5M
Gross Margin
59.2%
90.5%
Operating Margin
28.9%
12.4%
Net Margin
24.9%
4.4%
Revenue YoY
16.6%
32.8%
Net Profit YoY
21.3%
143.8%
EPS (diluted)
$2.72
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRMN
GRMN
ONC
ONC
Q4 25
$2.1B
$1.5B
Q3 25
$1.8B
$1.4B
Q2 25
$1.8B
$1.3B
Q1 25
$1.5B
$1.1B
Q4 24
$1.8B
$1.1B
Q3 24
$1.6B
$1.0B
Q2 24
$1.5B
$929.2M
Q1 24
$1.4B
$751.7M
Net Profit
GRMN
GRMN
ONC
ONC
Q4 25
$528.7M
$66.5M
Q3 25
$401.6M
$124.8M
Q2 25
$400.8M
$94.3M
Q1 25
$332.8M
$1.3M
Q4 24
$435.7M
$-151.9M
Q3 24
$399.1M
$-121.3M
Q2 24
$300.6M
$-120.4M
Q1 24
$276.0M
$-251.2M
Gross Margin
GRMN
GRMN
ONC
ONC
Q4 25
59.2%
90.5%
Q3 25
59.1%
86.1%
Q2 25
58.8%
87.5%
Q1 25
57.6%
85.2%
Q4 24
59.3%
85.8%
Q3 24
60.0%
83.0%
Q2 24
57.3%
85.1%
Q1 24
58.1%
83.4%
Operating Margin
GRMN
GRMN
ONC
ONC
Q4 25
28.9%
12.4%
Q3 25
25.8%
11.5%
Q2 25
26.0%
6.7%
Q1 25
21.7%
1.0%
Q4 24
28.3%
-7.0%
Q3 24
27.6%
-12.0%
Q2 24
22.7%
-11.5%
Q1 24
21.6%
-34.8%
Net Margin
GRMN
GRMN
ONC
ONC
Q4 25
24.9%
4.4%
Q3 25
22.7%
8.8%
Q2 25
22.1%
7.2%
Q1 25
21.7%
0.1%
Q4 24
23.9%
-13.5%
Q3 24
25.2%
-12.1%
Q2 24
20.0%
-13.0%
Q1 24
20.0%
-33.4%
EPS (diluted)
GRMN
GRMN
ONC
ONC
Q4 25
$2.72
$0.05
Q3 25
$2.08
$0.08
Q2 25
$2.07
$0.06
Q1 25
$1.72
$0.00
Q4 24
$2.24
$-0.10
Q3 24
$2.07
$-0.09
Q2 24
$1.56
$-0.09
Q1 24
$1.43
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRMN
GRMN
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$2.3B
$4.5B
Total DebtLower is stronger
$836.4M
Stockholders' EquityBook value
$9.0B
$4.4B
Total Assets
$11.0B
$8.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRMN
GRMN
ONC
ONC
Q4 25
$2.3B
$4.5B
Q3 25
$2.1B
$4.0B
Q2 25
$2.1B
$2.8B
Q1 25
$2.2B
$2.5B
Q4 24
$2.1B
$2.6B
Q3 24
$2.0B
$2.7B
Q2 24
$1.9B
$2.6B
Q1 24
$1.9B
$2.8B
Total Debt
GRMN
GRMN
ONC
ONC
Q4 25
$836.4M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GRMN
GRMN
ONC
ONC
Q4 25
$9.0B
$4.4B
Q3 25
$8.5B
$4.1B
Q2 25
$8.1B
$3.8B
Q1 25
$8.2B
$3.5B
Q4 24
$7.8B
$3.3B
Q3 24
$7.5B
$3.4B
Q2 24
$7.0B
$3.4B
Q1 24
$7.2B
$3.4B
Total Assets
GRMN
GRMN
ONC
ONC
Q4 25
$11.0B
$8.2B
Q3 25
$10.5B
$7.6B
Q2 25
$10.3B
$6.3B
Q1 25
$9.8B
$5.8B
Q4 24
$9.6B
$5.9B
Q3 24
$9.3B
$5.8B
Q2 24
$8.9B
$5.7B
Q1 24
$8.6B
$5.7B
Debt / Equity
GRMN
GRMN
ONC
ONC
Q4 25
0.19×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRMN
GRMN
ONC
ONC
Operating Cash FlowLast quarter
$553.8M
$417.3M
Free Cash FlowOCF − Capex
$429.6M
$379.8M
FCF MarginFCF / Revenue
20.2%
25.4%
Capex IntensityCapex / Revenue
5.8%
2.5%
Cash ConversionOCF / Net Profit
1.05×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRMN
GRMN
ONC
ONC
Q4 25
$553.8M
$417.3M
Q3 25
$485.6M
$402.6M
Q2 25
$173.2M
$263.6M
Q1 25
$420.8M
$44.1M
Q4 24
$483.9M
$75.2M
Q3 24
$258.0M
$188.4M
Q2 24
$255.3M
$-95.6M
Q1 24
$435.3M
$-308.6M
Free Cash Flow
GRMN
GRMN
ONC
ONC
Q4 25
$429.6M
$379.8M
Q3 25
$425.1M
$354.5M
Q2 25
$127.5M
$219.8M
Q1 25
$380.7M
$-12.3M
Q4 24
$399.2M
$-17.3M
Q3 24
$219.4M
$54.7M
Q2 24
$218.2M
$-205.5M
Q1 24
$402.1M
$-465.1M
FCF Margin
GRMN
GRMN
ONC
ONC
Q4 25
20.2%
25.4%
Q3 25
24.0%
25.1%
Q2 25
7.0%
16.7%
Q1 25
24.8%
-1.1%
Q4 24
21.9%
-1.5%
Q3 24
13.8%
5.5%
Q2 24
14.5%
-22.1%
Q1 24
29.1%
-61.9%
Capex Intensity
GRMN
GRMN
ONC
ONC
Q4 25
5.8%
2.5%
Q3 25
3.4%
3.4%
Q2 25
2.5%
3.3%
Q1 25
2.6%
5.0%
Q4 24
4.6%
8.2%
Q3 24
2.4%
13.3%
Q2 24
2.5%
11.8%
Q1 24
2.4%
20.8%
Cash Conversion
GRMN
GRMN
ONC
ONC
Q4 25
1.05×
6.28×
Q3 25
1.21×
3.22×
Q2 25
0.43×
2.79×
Q1 25
1.26×
34.71×
Q4 24
1.11×
Q3 24
0.65×
Q2 24
0.85×
Q1 24
1.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRMN
GRMN

Fitness Segment$765.8M36%
Outdoor Segment$627.6M30%
Marine Segment$296.9M14%
Aviation Segment$274.2M13%
Auto Oem Segment$160.4M8%

ONC
ONC

Segment breakdown not available.

Related Comparisons